NASDAQ
Amarantus BioScience Holdings, Inc. (AMBS) has a revenue compound annual growth rate of -15.67% over 5 years and -8.17% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.